Prognostic modeling of cutaneous melanoma stage I patients using cancer registry data identifies subsets with very‐low melanoma mortality-Reference-Cited by-同舟云学术

Prognostic modeling of cutaneous melanoma stage I patients using cancer registry data identifies subsets with very‐low melanoma mortality

Published:2022-11-07 Issue:1 Volume:129 Page:89-97
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Eguchi Megan M.¹^ORCID,Elder David E.²,Barnhill Raymond L.³⁴,Piepkorn Michael W.⁵⁶,Knezevich Stevan R.⁷,Elmore Joann G.¹^ORCID,Kerr Kathleen F.⁸^ORCID

Affiliation:

1. Department of Medicine University of California, Los Angeles, David Geffen School of Medicine Los Angeles California USA

2. Department of Pathology and Laboratory Medicine Hospital of the University of Pennsylvania Philadelphia Pennsylvania USA

3. Department of Translational Research Institut Curie Paris France

4. UFR of Medicine University of Paris Paris France

5. Division of Dermatology, Department of Medicine University of Washington School of Medicine Seattle Washington USA

6. Dermatopathology Northwest Bellevue Washington USA

7. Pathology Associates Clovis California USA

8. Department of Biostatistics University of Washington Seattle Washington USA

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34490

Reference31 articles.

1. Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

2. Model Predicting Survival in Stage I Melanoma Based on Tumor Progression

3. The histogenesis and biologic behavior of primary human malignant melanomas of the skin;Clark WH;Cancer Res,1969

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melanoma in situ and low risk pT1a melanoma: Need for new diagnostic terminology;Clinics in Dermatology;2024-09

2. In vitro and ex vivo evaluation of chitosan gel containing metformin-loaded polymeric nanoparticles for topical treatment of melanoma;Drug Development and Industrial Pharmacy;2024-07-02

3. Malignant Melanoma: An Overview, New Perspectives, and Vitamin D Signaling;Cancers;2024-06-18

4. Lived Experiences and Fear of Cancer Recurrence Among Survivors of Localized Cutaneous Melanoma;JAMA Dermatology;2024-05-01

5. Ecological study estimating melanoma overdiagnosis in the USA using the lifetime risk method;BMJ Evidence-Based Medicine;2024-01-19